Skip to main content
. 2020 Aug 20;64(9):e00836-20. doi: 10.1128/AAC.00836-20

FIG 3.

FIG 3

ATI-2173 is a potent and selective inhibitor of all HBV genotypes. (A) ATI-2173 inhibits HBV in HepG2 cells with an EC50 of 0.26 μM. (B) ATI-2173 inhibits HBV in primary human hepatocytes (PHHs) with an EC50 of 1.31 nM. (C) ATI-2173 is not genotype selective. (D) Summary of EC50 by genotype. GenBank IDs (left) correspond to the validated lab strains used in this assay.